Lyotropic chromonic liquid crystals as hydrophilic signal-transducing media for real-time monitoring and high-sensitivity detection of disease biomarkers
Abstract
This study investigates advanced label-free biosensing using the nematic phase of the lyotropic chromonic liquid crystal (LCLC) sunset yellow (SSY) to detect the cancer biomarker CA125 and SARS-CoV-2 nucleocapsid (N) protein. Unlike hydrophobic thermotropic LCs, SSY provides a hydrophilic medium that interacts more directly with biomolecules. Formation of antigen–antibody immunocomplexes at the LC–glass interface disrupted SSY orientation and produced measurable optical and dielectric changes. Quantification is achieved through three strategies, including polarizing optical microscopy image analysis, dielectric spectroscopy, and haze measurement. Optical analysis leveraged SSY absorption near 482 nm, while dielectric and haze measurements offered a simpler, more precise alternative to conventional image-based analysis. In addition, SSY enabled real-time monitoring and binding-kinetics analysis of antigen–antibody reactions. Kinetic fitting suggests distinct binding behaviors for CA125 versus SARS-CoV-2 N-protein immunocomplex formation. Together, these results position nematic SSY as a versatile signal-transducing medium for point-of-care screening of cancer and infectious diseases.